StonvexLoading…
StonvexStonvexStonvexCore line items from HSIC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $3.37B | $13.18B | $9.75B | $6.41B |
Operating Income | $182.00M | $653.00M | $490.00M | $326.00M |
Net Income | $107.00M | $398.00M | $297.00M | $196.00M |
EPS (Diluted) | $0.92 | $3.27 | $2.42 | $1.58 |
Total Assets | $11.30B | $11.21B | $11.10B | $10.91B |
Total Liabilities | $6.48B | $6.42B | $6.20B | $6.01B |
Cash & Equivalents | $138.00M | $156.00M | $136.00M | $145.00M |
Free Cash Flow OCF − CapEx | $-122.00M | $573.00M | $235.00M | $94.00M |
Shares Outstanding | 114.42M | 115.77M | 118.57M | 121.90M |